Skip to main content
. 2014 Sep;104(9):1774–1782. doi: 10.2105/AJPH.2014.302018

TABLE 1—

Model Input Parameters Used in Determining the Potential Cost-Effectiveness of School-Based Eating Disorder Screening

Parameter Mean Value (95% CI) Statistical Distribution Source
SCOFF, % Cotton et al.22
 Sensitivity 76 (62, 93) Triangular
 Specificity 88 (84, 93) Triangular
12-mo prevalence of ED, % National Comorbidity Survey, Swanson et al.1
 AN 0.2 (0.10, 0.30) Triangulara
 BN 0.6 (0.29, 0.91) Triangulara
 BED 0.9 (0.59, 1.21) Triangulara
 OSFED 1.1 (0.86, 1.33) Triangulara
Probability of seeking clinical treatment (no screen), % National Comorbidity Survey, Swanson et al.1
 AN 27.5 (4.9, 50.1) Triangulara
 BN 21.5 (10.6, 32.4) Triangulara
 BED 11.4 (5.6, 17.2) Triangulara
 OSFED 3.4 (1.0, 5.8) Triangulara
Probability of full recovery from specified ED with therapy, % Herzog et al.,23 Milos et al.,24 Lock et al.,25 Steinhausen26
 AN 18.2 (7.2, 35.0) Triangular
 BN 23.9 (18.1, 29.7) Triangular
 BEDc 28.1 (25.4, 30.8) Uniform
Probability of partial recovery from specified ED with therapy, % Milos et al.24
 AN 13.4 (8.7, 17.9) Uniform
 BN 15.2 (11.9, 18.3) Uniform
 BEDd 14.2 (10.3, 18.1) Uniform
OSFED progression and recovery probability, % Milos et al.24
 Progress from OSFED to AN with treatment 11.4 (6.1, 16.9) Uniform
 Progress from OSFED to BN with treatment 12.8 (1.9, 23.5) Uniform
 Progress from OSFED to BED with treatment 20.7 (14.1, 27.3) Uniform
 OSFED full recovery with treatment 28.1 (25.4, 30.8) Uniform
 Relative recovery probability without treatmentb 50 (26, 74) Uniform Assumption
Probability of relapse with therapy, %
 AN Variese (NA) Nonparametric Strober et al.,27 Olmsted et al.,28 Birchall et al.29
 BN Variese (NA) Nonparametric Herzog et al.,23 Grilo et al.,30 Keller et al.,31 Birchall et al.29
 AN or BN (sensitivity analysis) Variese (NA) Nonparametric Wang et al.,32 Eddy et al.33
 BED or OSFED 10.8 (NR) NA Milos et al.24
Utility values (scale = 0–1)
 AN 0.72 (NR) NA Vos and Mathers34
 Recovered from AN 0.91 (NR) NA de la Rie et al.35
 BN 0.8 (NR) NA Pohjolainen et al.36
 Recovered from BN 0.94 (NR) NA de la Rie et al.35
 BED or OSFED 0.77 (NR) NA Grenon et al.37
 Recovered from BED or OSFED 0.91 (NR) NA de la Rie et al.35
Screening costs, $
 Cost per SCOFF instrument 0.03 (0.01, 0.05) Uniform Assumption
 Teachers’ hourly wage 27.74 (NA) NA US National Compensation Survey38
Cost of initial diagnostic consultation, $ 134 (123, 144) Normal 2010 US Medical Expenditure Panel Survey39
Cost of standard therapy, $ Striegel-Moore et al.40
 AN 11 375 (271, 65 818)f Lognormal
 BN 5 574 (207, 30 066)f Lognormal
 BEDg 6 035 (113, 36 715)f Lognormal
Cost of low-intensity therapy, $ Striegel-Moore et al.40
 AN 4 411 (160, 23 672)f Lognormal
 BN 3 541 (207, 17 167)f Lognormal
 BED or OSFEDg 2 977 (223, 13 310)f Lognormal

Note. AN = anorexia nervosa; BED = binge-eating disorder; BN = bulimia nervosa; CI = confidence interval; ED = eating disorder; NA = not applicable; NR = not reported; OSFED = other specified feeding or eating disorder. SCOFF is a self-administered, 5-question ED screening instrument.20,21 We inflated all costs to 2012 dollars using the medical care component of the Consumer Price Index.41

a

The primary source reported means and standard deviations for these estimates. We calculated the 95% confidence interval from these estimates assuming a normal distribution, and a triangular distribution was used in the model to avoid sampling negative probabilities in uncertainty analyses.

b

We assumed that without treatment, recovery rates would be 25% to 75% lower than recovery rates with treatment. This value was randomly sampled from a uniform distribution.

c

Derived from eating disorder not otherwise specified (ED-NOS) recovery probability.

d

Assumed to be the average of AN and BN partial recovery probabilities.

e

Probability varies on the basis of number of years of treatment received. In the base case analysis, AN and BN recovery probabilities ranged from 2.3% to 17.1% and 4.9% to 48.5%, respectively, over 10 years. In the sensitivity analysis, recovery probabilities were 0%, 19%, 29%, 40%, 43%, 47%, and 50% for the first 7 years of treatment, respectively, and 100% afterward.

f

A lognormal distribution was used to model the 95% confidence interval to represent the positively skewed distribution that is typical of cost data. The mean and standard deviation that were reported in the literature were transformed into the mean of logs and standard deviation of logs to simulate the lognormal distribution.42

g

Reported as ED-NOS in the original study. As BED was formerly part of ED-NOS,18 we used the same treatment costs for BED and OSFED.